{"id":"W4393121545","doi":"10.1177/17562864241239453","title":"Comparative efficacy of ofatumumab <i>versus</i> oral therapies for relapsing multiple sclerosis patients using propensity score analyses and simulated treatment comparisons","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"Novartis Australia","keywords":"Fingolimod; Medicine; Cladribine; Ofatumumab; Teriflunomide; Placebo; Internal medicine; Multiple sclerosis; Natalizumab; Disease; Alternative medicine; Immunology; Rituximab; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001269565,0.0003028375,0.000835597,0.0001640335,0.0001594673,0.0000292137,0.00009640715,0.00008122351,0.00001111056],"category_scores_gemma":[0.0002054562,0.0001972699,0.0001621189,0.0004276334,0.0006845208,0.0001826327,0.00007747671,0.0002188598,7.464524e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005810013,"about_ca_system_score_gemma":0.00003736412,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007006162,"about_ca_topic_score_gemma":0.0001708789,"domain_scores_codex":[0.9981806,0.0002185396,0.0004074829,0.0005340246,0.0002688462,0.0003905008],"domain_scores_gemma":[0.9975534,0.001972744,0.00009807244,0.0001968557,0.0001001896,0.00007871877],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02405943,0.003439223,0.7361139,0.0003856405,0.001143598,0.000006163102,0.003683054,0.02328047,0.01713916,0.0000821421,0.00001546517,0.1906517],"study_design_scores_gemma":[0.01733853,0.006349515,0.7864602,0.0003420265,0.0003845085,7.909912e-7,0.0004425766,0.1854089,0.001088365,0.0002797914,0.001576955,0.0003278953],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9806585,0.01556046,0.001459305,0.000207673,0.0001298379,0.001833282,0.0000381292,0.00007415519,0.00003862849],"genre_scores_gemma":[0.9921855,0.006282432,0.001347126,0.00007482656,0.00001455262,0.00004248357,0.00002582053,0.00002293418,0.000004305517],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1903238,"threshold_uncertainty_score":0.8044433,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3913923956294829,"score_gpt":0.4403275504441665,"score_spread":0.04893515481468363,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}